Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1

Journal of Cell Biology

Volumn 139, Issue 7, 1997, Pages 1621-1634

  Sternsdorf, Thomas ^a   Jensen, Kirsten ^a   Will, Hans ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; INTERFERON; NUCLEAR PROTEIN; UBIQUITIN;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL FRACTIONATION; COVALENT BOND; IMMUNITY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; LEUKEMOID REACTION; MALIGNANT TRANSFORMATION; MITOSIS; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN STRUCTURE; RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NUCLEAR; AUTOANTIGENS; CELL NUCLEUS; CROSS REACTIONS; HELA CELLS; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOBLOTTING; INTERFERONS; MICROSCOPY, FLUORESCENCE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PEPTIDES; PRECIPITIN TESTS; RATS; RNA SPLICING; SUMO-1 PROTEIN; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UBIQUITINS; VARIATION (GENETICS); XENOPUS PROTEINS;

ANIMALIA;

EID: 0031426631     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.139.7.1621     Document Type: Article

References (69)

1. Ahn, M.-J., K. Nason-Burchenal, M.M. Moasser, and E. Dmitrovsky. 1995. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RARα or PML. Oncogene. 10: 2307-2314.
2. Altabef, M., M. Garcia, C. Lavau, S.-C. Bae, A. Dejean, and J. Samarut. 1996. A retrovirus carrying the promyelocyte-retinoic acid receptor PML-RARα fusion gene transforms haematopoietic progenitors in vitro and induces acute leukaemias. EMBO (Eur. Mol. Biol. Organ.) J. 15:2707-2716.
3. Arnason, T., and M.J. Ellison. 1994. Stress resistance in Saccharornyces cerevisiae is strongly correlated with assembly of a novel type of multiubiquitin chain. Mol. Cell. Biol. 14:7876-7883.
4. Ascoli, C.A., and G.G. Maul. 1991. Identification of a novel nuclear domain. J. Cell Biol. 112:785-795.
5. Aso, T., W.S. Lane, J.W. Conaway, and R.C. Conaway. 1995. Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II. Science. 269: 1439-1443.
6. Baboshina, O.V., and A.L. Haas. 1996. Novel multiubiquitin chain linkages catalyzed by the conjugating enzymes E2EPF and RAD6 are recognized by 26 S proteasome subunit 5. J. Biol. Chem. 271:2823-2831.
7. Bernstein, R.M., J.M. Neuberger, C.C. Bunn, M.E. Callender, G.R. Hughes, and R. Williams. 1984. Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis. Clin. Exp. Immunol. 55:553-560.
8. Biggins, S., I. Ivanovska, and M.D. Rose. 1996. Yeast ubiquitin-like genes are involved in duplication of the microtubule organizing center. J. Cell Biol. 133:1331-1346.
9. Bloch, D.B., S.M. de la Monte, P. Guigaouri, A. Filippov, and K.D. Bloch. 1996. Identification and characterization of a leukocyte-specific component of the nuclear body. J Biol. Chem. 271:29198-29204.
10. Boddy, M.N., K. Howe, L.D. Etkin, E. Solomon, and P.S. Freemont. 1996. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene. 13:971-982.
11. Brasch, K., and R.L. Ochs. 1992. Nuclear bodies (NBs): a newly -"rediscovered" organelle. Exp. Cell Res. 202:211-223.
12. Brown, D., S. Kogan, E. Lagasse, I. Weissman, M. Alcalay, P.G. Pelicci, S. Atwater, and J.M. Bishop. 1997. A PMLRARα transgene initiates murine acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA. 94:2551-2556.
13. Carvalho, T., J.S. Seeler, K. Ohman, P. Jordan, U. Pettersson, G. Akusjarvi, M. Carmo-Fonseca, and A. Dejean. 1995. Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J. Cell Biol. 131: 45-56.
14. Chelbi-Alix, M.K., L. Pelicano, F. Quignon, M.H.M. Koken, L. Venturini, M. Stadler, J. Pavlovic, L. Degos, and H. de Thé. 1995. Induction of the PML protein by interferons in normal and APL cells. Leukemia. 9:2027-2033.
15. Daniel, M.T., M.H.M. Koken, O. Romagne, S. Barbey, A. Bazarbachi, M. Stadler, M.C. Guillemin, L. Degos, C. Chomienne, and H. de Thé. 1993. PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood. 82:1858-1867.
16. de Thé, H., C. Chomienne, M. Lanotte, L. Degos, and A. Dejean. 1990. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor a gene to a novel transcribed locus. Nature. 347:558-561.
17. de Thé, H., C. Lavau, A. Marchio, C. Chomienne, L. Degos, and A. Dejean. 1991. The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell. 66:675-684.
18. Dent, A.L., J. Yewdell, F. Puviondutilleul, M.H.M. Koken, H. de Thé, and L.M. Staudt. 1996. LYSP100-associated nuclear domains (LANDs): description of a new class of subnuclear structures and their relationship to PML nuclear bodies. Blood. 88:1423-1436.
19. Desbois, C., R. Rousset, F. Bantignies, and P. Jalinot. 1996. Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I tax oncoprotein. Science. 273:951-953.
20. Dignam, J.D., R.M. Lebovitz, and R.G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
21. Dyck, J.A., G.G. Maul, W.J. Miller, J.D. Chen, A. Kakizuka, and R.M. Evans. 1994. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell. 76:333-343.
22. Everett, R.D., M. Meredith, A. Orr, A. Cross, M. Kathoria, and J. Parkinson. 1997. A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO (Eur. Mol. Biol. Organ.) J. 16:566-577.
23. Gambacorta, M., L. Flenghi, M. Fagioli, S. Pileri, L. Leoncini, B. Bigerna, R. Pacini, L.N. Tanci, L. Pasqualucci, S. Ascani, et al. 1996. Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. Am. J. Pathol. 149:2023-2035.
24. Garrett, K.P., T. Aso, J.N. Bradsher, S.I. Foundling, W.S. Lane, R.C. Conaway, and J.W. Conaway. 1995. Positive regulation of general transcription factor SIII by a tailed ubiquitin homolog. Proc. Natl. Acad. Sci. USA. 92:7172-7176.
25. Goddard, A.D., J. Borrow, P.S. Freemont, and E. Solomon. 1991. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science. 254:1371-1374.
26. Grisolano, J.L., R.L. Wesselschmidt, P.G. Pelicci, and T.J. Ley. 1997. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RARα under control of cathepsin G regulatory sequences. Blood. 89: 376-387.
27. Grötzinger, T., K. Jensen, H.H. Guldner, T. Sternsdorf, C. Szostecki, M. Schwab, L. Savelyeva, B. Reich, and H. Will. 1996a. A highly amplified mouse gene is homologous to the human interferon-responsive Sp100 gene encoding an autoantigen associated with nuclear dots. Mol. Cell. Biol. 16: 1150-1156.
28. Grötzinger, T., T. Sternsdorf, K. Jensen, and H. Will. 1996b. Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). Eur. J. Biochem. 238: 554-560.
29. Guldner, H.H., C. Szostecki, T. Grötzinger, and H. Will. 1992. IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis. J. Immunol. 149:4067-4073.
30. Hochstrasser, M. 1996a. Protein degradation or regulation: Ub the judge. Cell. 84:813-815.
31. Hochstrasser, M. 1996b. Ubiquitin-dependent protein degradation. Annu. Rev. Genet. 30:405-439.
32. Hodgins, R., C. Gwozd, T. Arnason, M. Cummings, and M.J. Ellison. 1996. The tail of a ubiquitin-conjugating enzyme redirects multi-ubiquitin chain synthesis from the lysine 48-linked configuration to a novel nonlysine-linked form. J. Biol. Chem. 271:28766-28771.
33. Huang, M.E., Y.C. Ye, S.R. Chen, J.R. Chai, J.X. Lu, L. Zhoa, L.J. Gu, and Z.Y. Wang. 1988. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 72:567-572.
34. Kakizuka, A., W.J. Miller, K. Umesono, R.J. Warrell, S.R. Frankel, V.V. Murty, E. Dmitrovsky, and R.M. Evans. 1991. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML. Cell. 66:663-674.
35. Kamitani, T., H.P. Nguyen, and E.T. Yeh. 1997. Preferential modification of nuclear proteins by a novel ubiquitin-like molecule. J. Biol. Chem. 272: 14001-14004.
36. Kitamura, T., T. Tange, T. Terasawa, S. Chiba, T. Kuwaki, K. Miyagawa, Y-F. Piao, K. Miyazono, A. Urabe, and F. Takaku. 1989. Establishment and characterization of a unique human cell line that proliferates dependency on GM-CSF, IL-3, or erythropoietin. J. Cell Physiol. 140:323-334.
37. Koken, M.H.M., D.F. Puvion, M.C. Guillemin, A. Viron, G. Linarez-Cruz, N. Stuurman, L. de Jong, C. Szostecki, F. Calvo, C. Chomienne, et al. 1994. The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO (Eur. Mol. Biol. Organ.) J. 13:1073-1083.
38. Koken, M.H.M., G. Linares-Cruz, F. Quignon, A. Viron, M.K. Chelbi-Alix, J. Sobczak-Thepot, L. Juhlin, L. Degos, F. Calvo, and H. de Thé. 1995. The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene. 10:1315-1324.
39. Korioth, F., G.G. Maul, B. Plachter, T. Stamminger, and J. Frey. 1996. The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp. Cell Res. 229:155-158.
40. Kovalenko, O.V., A.W. Plug, T. Haaf, D.K. Gonda, T. Ashley, D.C. Ward, C.M. Radding, and E.I. Golub. 1996. Mammalian ubiquitin-conjugating enzyme Ubc9 interacts with Rad51 recombination protein and localizes in synaplonemal complexes. Proc. Natl. Acad. Sci. USA. 93:2958-2963.
41. Lavau, C., A. Marchio, M. Fagioli, J. Jansen, B. Falini, P. Lebon, F. Grosveld, P.P. Pandolfi, P.G. Pelicci, and A. Dejean. 1995. The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene. 11:871-878.
42. Le, X.F., P. Yang, and K.S. Chang. 1996. Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML. J. Biol. Chem. 271:130-135.
43. Loeb, K.R., and A.L. Haas. 1992. The interferon-inducible 15-kD ubiquitin homolog conjugates to intracellular proteins. J. Biol. Chem. 267:7806-7813.
44. Mahajan, R., C. Delphin, T. Guan, L. Gerace, and F. Melchior. 1997. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell. 88:97-107.
45. Matunis, M.J., E. Coutavas, and G. Blobel. 1996. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135:1457-1470.
46. Maul, G.G., H.H. Guldner, and J.G. Spivack. 1993. Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). J. Gen. Virol. 74:2679-2690.
47. Maul, G.G., E. Yu, A.M. Ishov, and A.L. Epstein. 1995. Nuclear domain 10 (ND10) associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites alter stress. J. Cell Biochem. 59:498-513.
48. Mu, Z.M., K.V. Chin, J.H. Liu, G. Lozano, and K.S. Chang. 1994. PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell. Biol. 14:6858-6867.
49. Nakamura, M., R.M. Xavier, T. Tsunematsu, and Y. Tanigawa. 1995. Molecular cloning and characterization of a cDNA encoding monoclonal nonspecific suppressor factor. Proc. Natl. Acad. Sci. USA. 92:3463-3467.
50. Okura, T., L. Gong, T. Kamitani, T. Wada, I. Okura, C.F. Wei, H.M. Chang, and E.T. Yeh. 1996. Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J. Immunol. 157:4277-4281.
51. Powell, F., A.L. Schroeter, and E.R. Dickson. 1984. Anti-nuclear antibodies in primary biliary cirrhosis. Lancet. 1:288-289.
52. Raska, I., M. Dundr, and K. Koberna. 1992. Structure-function subcompartments of the mammalian cell nucleus as revealed by the electron microscopic affinity cytochemistry. Cell Biol. Int. Rep. 16:771-789.
53. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual. Second Edition, Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY. 545 pp.
54. Scully, R., J. Chen, A. Plug, Y. Xiao, D. Weaver, J. Feunteun, T. Ashley, and D.M. Livingston. 1997. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell. 88:265-275.
55. Shen, Z., P.E. Pardington-Purtymun, J.C. Comeaux, R.K. Moyzis, and D.J. Chen. 1996a. Associations of UBE21 with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system. Genomics. 37:183-186.
56. Shen, Z., P.E. Pardington-Purtymun, J.C. Comeaux, R.K. Moyzis, and D.J. Chen. 1996b. UBL1, a human ubiquitin-like protein associating with human RAD51/RAD52 proteins. Genomics. 36:271-279.
57. Sternsdorf, T., H.H. Guldner, C. Szostecki, T. Grötzinger, and H. Will. 1995. Two nuclear-dot associated proteins. PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis. Scand. J. Immunol. 42: 257-268.
58. Sternsdorf, T., T. Grötzinger, K. Jensen, and H. Will. 1997a. Nuclear dots: actors on many stages. Immunobiolology. In press.
59. Sternsdorf, T., K. Jensen, D, Züchner, and H. Will. 1997b. Cellular localization, expression, and structure of the nuclear dot protein 52. J. Cell Biol. 138:435-448.
60. Stuurman, N., A. de Graaf, A. Floore, A. Josso, B. Humbel, L. de Jong, and R. van Driel. 1992. A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J. Cell Sci. 101:773-784.
61. Szostecki, C., H. Krippner, E. Penner, and F.A. Bautz. 1987. Autoimmune sera recognize a 100 kD nuclear protein antigen (Sp100). Clin. Exp. Immunol. 68: 108-116.
62. Szostecki, C., H.H. Guldner, H.J. Netter, and H. Will. 1990. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J. Immunol. 145:4338-4347.
63. Szostecki, C., H.H. Guldner, and H. Will. 1997. Autoantibodies against "nuclear dots" in primary biliary cirrhosis. Semin. Liver Dis. 17:71-78.
64. Van de Water, J., D. Fregeau, P. Davis, A. Ansari, D. Danner, P. Leung, R. Coppel, and M.E. Gershwin. 1988. Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function. J. Immunol. 141:2321-2324.
65. Watkins, J.F., P. Sung, L. Prakash, and S. Prakash. 1993. The Saccharomyces cerevisiae DNA repair gene RAD23 encodes a nuclear protein containing a ubiquitin-like domain required for biological function. Mol. Cell. Biol. 13: 7757-7765.
66. Weichenhan, D., B. Kunze, S. Zacker, W. Traut, and H. Winking. 1997. Structure and expression of the murine Sp100 nuclear dot gene. Genomics. 43: 298-306.
67. Weis, K., S. Rambaud, C. Lavau, J. Jansen, T. Carvalho, M. Carmo-Fonseca, A. Lamond, and A. Dejean. 1994. Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells. Cell. 76: 345-356.
68. Xie, K., E.J. Lambie, and M. Snyder. 1993. Nuclear dot antigens may specify transcriptional domains in the nucleus. Mol. Cell. Biol. 13:6170-6179.
69. Yasugi, T., and P.M. Howley. 1996. Identification of the structural and functional human homolog of the yeast ubiquitin conjugating enzyme UBC9, Nucleic Acids Res. 24:2005-2010.